Clearing the smokescreen: The current evidence on cannabis use

Cannabis remains the most commonly used illicit substance world-wide, with international estimates indicating that 2.8%-4.5% of the global population use cannabis each year. This prevalence rate has not changed substantially in the past decade and there is no indication that it will do so in the nex...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Margriet van Laar, Elizabeth C. Temple, Rhonda F. Brown, Richard Hammersley
Materyal Türü: Online
Dil:İngilizce
Baskı/Yayın Bilgisi: Frontiers Media SA 2021
Konular:
Online Erişim:17823
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
_version_ 1869519536470884352
author Margriet van Laar
Elizabeth C. Temple
Rhonda F. Brown
Richard Hammersley
author_browse Elizabeth C. Temple
Margriet van Laar
Rhonda F. Brown
Richard Hammersley
author_facet Margriet van Laar
Elizabeth C. Temple
Rhonda F. Brown
Richard Hammersley
author_sort Margriet van Laar
collection Directory of Open Access Books
description Cannabis remains the most commonly used illicit substance world-wide, with international estimates indicating that 2.8%-4.5% of the global population use cannabis each year. This prevalence rate has not changed substantially in the past decade and there is no indication that it will do so in the next decade. In line with this, many prominent organizations and individuals have acknowledged that the “war on drugs” has failed and are now calling for a rethink on drug-related policy and legal frameworks. With a growing number of jurisdictions across the world heeding this call and introducing legislation to decriminalize or legalize cannabis use, it is essential that any changes to legal frameworks and public health policies are based on the best available scientific evidence. To facilitate the adoption of an evidence-based approach to cannabis policy, the aim of this Research Topic was to gather a comprehensive body of research to clarify the current state of evidence relating to cannabis use. Of interest were articles addressing the following questions: • How do we study cannabis use? (e.g., recruitment; measuring dose/use; assessing dependence/problematic use; confounding; translation of findings from animal studies) • What do we know about cannabis use? (e.g., patterns, contexts, methods of use) • What do we know about people who use cannabis? (e.g., who uses cannabis and why) • What are the social settings, norms and cultural values that go along with cannabis use? • How is problematic cannabis use, as opposed to mere use, defined, judged and constructed in different societies? • What do we know about the effects/outcomes of cannabis use? (e.g., acute, short- and long-term; harms/ benefits) • What do we know about the factors associated with the initiation, continuance and cessation of cannabis use? • What do we know about the medicinal use of cannabis? (e.g., who uses medicinally and why; efficacy/effectiveness in different clinical populations; comparison with other medications) • What do we know about treatment for people who engage in problematic cannabis use? (e.g., who seeks/is referred to treatment and why; efficacy and effectiveness) • What do we know about cannabis? (e.g., pharmacodynamics/pharmacokinetics of different strains, cultivation, preparation and consumption methods) • How do policy and legal frameworks impact on the people who use cannabis? • What is the future for cannabis research? (e.g., potential avenues for future research; aspects needing more attention; innovative approaches; political/funding issues affecting cannabis research)
format Online
id doab-20.500.12854ir-43354
institution Directory of Open Access Books
language eng
publishDate 2021
publishDateRange 2021
publishDateSort 2021
publisher Frontiers Media SA
publisherStr Frontiers Media SA
record_format ojs
spelling doab-20.500.12854ir-433542024-03-30T23:22:31Z Clearing the smokescreen: The current evidence on cannabis use Margriet van Laar Elizabeth C. Temple Rhonda F. Brown Richard Hammersley R5-920 RC435-571 Cannabis Cannabinoids Affective disorders anxiety Addiction normalization marijuana legalization drug policy psychosis thema EDItEUR::M Medicine and Nursing Cannabis remains the most commonly used illicit substance world-wide, with international estimates indicating that 2.8%-4.5% of the global population use cannabis each year. This prevalence rate has not changed substantially in the past decade and there is no indication that it will do so in the next decade. In line with this, many prominent organizations and individuals have acknowledged that the “war on drugs” has failed and are now calling for a rethink on drug-related policy and legal frameworks. With a growing number of jurisdictions across the world heeding this call and introducing legislation to decriminalize or legalize cannabis use, it is essential that any changes to legal frameworks and public health policies are based on the best available scientific evidence. To facilitate the adoption of an evidence-based approach to cannabis policy, the aim of this Research Topic was to gather a comprehensive body of research to clarify the current state of evidence relating to cannabis use. Of interest were articles addressing the following questions: • How do we study cannabis use? (e.g., recruitment; measuring dose/use; assessing dependence/problematic use; confounding; translation of findings from animal studies) • What do we know about cannabis use? (e.g., patterns, contexts, methods of use) • What do we know about people who use cannabis? (e.g., who uses cannabis and why) • What are the social settings, norms and cultural values that go along with cannabis use? • How is problematic cannabis use, as opposed to mere use, defined, judged and constructed in different societies? • What do we know about the effects/outcomes of cannabis use? (e.g., acute, short- and long-term; harms/ benefits) • What do we know about the factors associated with the initiation, continuance and cessation of cannabis use? • What do we know about the medicinal use of cannabis? (e.g., who uses medicinally and why; efficacy/effectiveness in different clinical populations; comparison with other medications) • What do we know about treatment for people who engage in problematic cannabis use? (e.g., who seeks/is referred to treatment and why; efficacy and effectiveness) • What do we know about cannabis? (e.g., pharmacodynamics/pharmacokinetics of different strains, cultivation, preparation and consumption methods) • How do policy and legal frameworks impact on the people who use cannabis? • What is the future for cannabis research? (e.g., potential avenues for future research; aspects needing more attention; innovative approaches; political/funding issues affecting cannabis research) 2021-02-11T09:59:30Z 2021-02-11T09:59:30Z 2015-12-10 11:59:06 2015 book 17823 16648714 9782889195275 https://directory.doabooks.org/handle/20.500.12854/43354 eng Frontiers Research Topics image/jpeg Attribution 4.0 International http://www.frontiersin.org/books/Clearing_the_smokescreen_The_current_evidence_on_cannabis_use/522#nogo http://journal.frontiersin.org/researchtopic/1138/clearing-the-smokescreen-the-current-evidence-on-cannabis-use Frontiers Media SA 10.3389/978-2-88919-527-5 10.3389/978-2-88919-527-5 bf5ce210-e72e-4860-ba9b-c305640ff3ae 9782889195275 171 open access
spellingShingle R5-920
RC435-571
Cannabis
Cannabinoids
Affective disorders anxiety
Addiction
normalization
marijuana
legalization
drug policy
psychosis
thema EDItEUR::M Medicine and Nursing
Margriet van Laar
Elizabeth C. Temple
Rhonda F. Brown
Richard Hammersley
Clearing the smokescreen: The current evidence on cannabis use
title Clearing the smokescreen: The current evidence on cannabis use
title_full Clearing the smokescreen: The current evidence on cannabis use
title_fullStr Clearing the smokescreen: The current evidence on cannabis use
title_full_unstemmed Clearing the smokescreen: The current evidence on cannabis use
title_short Clearing the smokescreen: The current evidence on cannabis use
title_sort clearing the smokescreen the current evidence on cannabis use
topic R5-920
RC435-571
Cannabis
Cannabinoids
Affective disorders anxiety
Addiction
normalization
marijuana
legalization
drug policy
psychosis
thema EDItEUR::M Medicine and Nursing
topic_facet R5-920
RC435-571
Cannabis
Cannabinoids
Affective disorders anxiety
Addiction
normalization
marijuana
legalization
drug policy
psychosis
thema EDItEUR::M Medicine and Nursing
url 17823
work_keys_str_mv AT margrietvanlaar clearingthesmokescreenthecurrentevidenceoncannabisuse
AT elizabethctemple clearingthesmokescreenthecurrentevidenceoncannabisuse
AT rhondafbrown clearingthesmokescreenthecurrentevidenceoncannabisuse
AT richardhammersley clearingthesmokescreenthecurrentevidenceoncannabisuse